Sarepta Therapeutics jobs

MSL Team Lead - US East 4 Locations posted: Posted 16 Days Ago

Law Clerk Co-op 2 Locations posted: Posted 16 Days Ago

Clinical Trial Manager Viking Therapeutics, Inc. Clinical Trial Manager

Drug Safety Manager Viking Therapeutics, Inc. Drug Safety Manager

Director of Process Validation Viking Therapeutics, Inc. Director of Process Validation

Medical Science Liaison Director/Lead Viking Therapeutics, Inc. Medical Science Liaison Director/Lead

Associate Director, Formulation Development Viking Therapeutics, Inc. Associate Director, Formulation Development

Senior/Executive Director, Health Economics & Outcomes Research (HEOR) Viking Therapeutics, Inc. Senior/Executive Director, Health Economics & Outcomes Research (HEOR)

Therapeutic Mentor Bradenton, Florida posted: Posted 2 Days Ago

Therapeutic Specialist Spain - Alicante posted: Posted 2 Days Ago

Therapeutic Specialist I China - Kunming posted: Posted 30+ Days Ago

Therapeutic Specialist II China - Shenyang posted: Posted 24 Days Ago

Senior Therapeutic Specialist Norway - Oslo posted: Posted 30 Days Ago

Vice President, Commercial Manufacturing Operations Remote Vera Therapeutics is a biotechnology company focused on developing treatments for serious immunological diseases. Vera Therapeutics' mission is to advance treatments that target the source of disease in order to change the standard of care for patients. Vera Therapeutics' lead product candidate is atacicept, a fusion protein self-administered at home as a subcutaneous once weekly injection that blocks both B-cell Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL), which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including IgA nephropathy (IgAN) and lupus nephritis. Beyond IgAN, Vera Therapeutics is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove clinically meaningful. In addition, Vera Therapeutics holds an exclusive license agreement with Stanford University for a novel, next generation fusion protein targeting BAFF and APRIL, known as VT-109, with wide therapeutic potential across the spectrum of B-cell-mediated diseases. Vera Therapeutics is also evaluating the development of MAU868, a monoclonal antibody designed to neutralize infection with BK virus, which can have devastating consequences in kidney transplant recipients. Vera Therapeutics retains all global developmental and commercial rights to atacicept, VT-109, and MAU868. For more information, please visit www.veratx.com . Our values are the cornerstone of our culture. Our values inspire us every day and guide everything we do-from how we hire great people, to advancing our mission together, to achieving our ultimate goal to improve medical treatment for patients suffering from immunological diseases. Position Summary: The Vice President, Manufacturing Operations will report

Senior Therapeutic Specialist II China - Tianjin posted: Posted 30+ Days Ago

Veterinary Integration Lead – Therapeutic Diagnostics Parsippany posted: Posted 22 Days Ago

Sr Therapeutic Specialist - HIV Australia - Sydney posted: Posted 30+ Days Ago

Sr Therapeutic Specialist (愛知県) - 肝臓領域 Japan - Tokyo posted: Posted Today

Sr Therapeutic Specialist（関西） Japan - Tokyo posted: Posted 9 Days Ago

Head, Oncology Immune Therapeutics Cambridge (USA) posted: Posted 22 Days Ago

Senior Scientist, Multiomic Therapeutics 2 Locations posted: Posted 8 Days Ago

CV Therapeutic Area Lead South Korea - Seoul posted: Posted 30+ Days Ago

Senior Therapeutic Specialist, Oncology 7 Locations posted: Posted 30+ Days Ago

Principal Scientist, Peptide Therapeutics South San Francisco, California, United States of America This is a primarily lab-based, technical leadership position within the Peptide Therapeutics department. In this lab-based leadership role, you will combine hands-on synthetic expertise with strategic...